‘Breakthrough’ dementia drug looks to stop disease in its tracks

A novel dementia drug protects against the destruction of key brain cell structures

Filamon Limited, an Australian biotech company focused on developing next-gen anti-inflammatory drugs, has announced its breakthrough dementia treatment. ALPHA-003 is designed to preserve the integrity of vital brain cell structures and protect them against destruction caused by brain inflammation.

Continue Reading

Category: Alzheimer’s & Dementia, Brain Health, Body & Mind

Tags: , , ,